Neuromod’s Tinnitus Treatment Device Validated by Clinical Trial Results
Nature Communications published peer-reviewed results of Neuromod's TENT-A3 clinical trial, validating its tinnitus treatment device, Lenire.
Nature Communications published peer-reviewed results of Neuromod's TENT-A3 clinical trial, validating its tinnitus treatment device, Lenire.
Medical device company, Neuromod Devices Ltd, announced that it has launched Ótologie, a “specialist telehealth service for tinnitus.” This new service will provide tinnitus patients, throughout the United Kingdom and Europe, with a private care option to avoid waiting lists and give them immediate access to treatment from its telehealth service.